10-Q Filing

ARROWHEAD PHARMACEUTICALS, INC. CIK: 879407 Q3 2014

Filing Information

Form Type	10-Q
Accession Number	`0001564590-14-003557`
Period End Date	20140630
Filing Date	20140812
Fiscal Year	2014
Fiscal Period	Q3
XBRL Instance	arwr-20140630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 83 Income Statement 90 Cash Flow Statement 90 Stockholders Equity 17

Balance Sheet 83 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$138.35M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.38M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$19.11M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	21,291.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	9,900.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$29.03M	USD	Point-in-time
Trade receivable	`AccountsReceivableNetCurrent`	$75.00K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	9,900.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	21,291.00	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$532.35K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$700.06K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	145.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	145.00M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$538.74K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$91.66K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	52.91M	shares	Point-in-time
Short term investments	`MarketableSecuritiesCurrent`	$9.03M	USD	Point-in-time
Short term investments	`MarketableSecuritiesCurrent`	$23.83M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	32.49M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	32.49M	shares	Point-in-time
TOTAL CURRENT ASSETS	`AssetsCurrent`	$163.42M	USD	Point-in-time
TOTAL CURRENT ASSETS	`AssetsCurrent`	$28.84M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	52.91M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$3.51M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$3.67M	USD	Point-in-time
Patents and other intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$3.20M	USD	Point-in-time
Patents and other intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$3.24M	USD	Point-in-time
Patents and other intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$4.78M	USD	Point-in-time
Investments	`MarketableSecuritiesNoncurrent`	$26.28M	USD	Point-in-time
Investments	`MarketableSecuritiesNoncurrent`	$1.70M	USD	Point-in-time
Other assets	`OtherAssetsMiscellaneousNoncurrent`	$30.01K	USD	Point-in-time
Other assets	`OtherAssetsMiscellaneousNoncurrent`	$41.41K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$37.33M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$196.62M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.20M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$2.16M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$638.88K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.07M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$611.09K	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$905.77K	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$71.88K	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$103.12K	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilities`	$4.02M	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilities`	$4.10M	USD	Point-in-time
Capital lease obligation	`CapitalLeaseObligationsCurrent`	$213.11K	USD	Point-in-time
Capital lease obligation	`CapitalLeaseObligationsCurrent`	$221.34K	USD	Point-in-time
Notes payable	`NotesPayableCurrent`	$971.56K	USD	Point-in-time
Notes payable	`NotesPayableCurrent`	$50.00K	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$588.34K	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$58.50K	USD	Point-in-time
TOTAL CURRENT LIABILITIES	`LiabilitiesCurrent`	$8.73M	USD	Point-in-time
TOTAL CURRENT LIABILITIES	`LiabilitiesCurrent`	$8.25M	USD	Point-in-time
Notes payable, net of current portion	`LongTermNotesPayable`	$50.00K	USD	Point-in-time
Capital lease obligation, net of current portion	`CapitalLeaseObligationsNoncurrent`	$1.06M	USD	Point-in-time
Capital lease obligation, net of current portion	`CapitalLeaseObligationsNoncurrent`	$812.17K	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$1.75M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$1.76M	USD	Point-in-time
TOTAL LONG-TERM LIABILITIES	`LiabilitiesNoncurrent`	$2.56M	USD	Point-in-time
TOTAL LONG-TERM LIABILITIES	`LiabilitiesNoncurrent`	$2.87M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized; 21,291 and 9,900 shares issued and outstanding as of June 30, 2014 and September 30, 2013, respectively	`PreferredStockValue`	$21.00	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized; 21,291 and 9,900 shares issued and outstanding as of June 30, 2014 and September 30, 2013, respectively	`PreferredStockValue`	$10.00	USD	Point-in-time
Common stock, $0.001 par value; 145,000,000 shares authorized; 52,908,567 and 32,489,444 shares issued and outstanding as of June 30, 2014 and September 30, 2013, respectively	`CommonStockValue`	$145.28K	USD	Point-in-time
Common stock, $0.001 par value; 145,000,000 shares authorized; 52,908,567 and 32,489,444 shares issued and outstanding as of June 30, 2014 and September 30, 2013, respectively	`CommonStockValue`	$124.86K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$388.56M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$193.51M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-202.34M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-166.14M	USD	Point-in-time
Total Arrowhead Research Corporation stockholders' equity	`StockholdersEquity`	$27.50M	USD	Point-in-time
Total Arrowhead Research Corporation stockholders' equity	`StockholdersEquity`	$186.36M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$-1.76M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$-555.10K	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$185.81M	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$25.73M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$37.33M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$196.62M	USD	Point-in-time

Income Statement 90 line items

Line Item	Tag	Value	Unit	Period
REVENUE	`Revenues`	$131.25K	USD	3 Qtrs
REVENUE	`Revenues`	$246.52K	USD	3 Qtrs
REVENUE	`Revenues`	$43.75K	USD	1 Quarter
REVENUE	`Revenues`	$43.75K	USD	1 Quarter
Salaries and payroll-related costs	`LaborAndRelatedExpense`	$7.63M	USD	3 Qtrs
Salaries and payroll-related costs	`LaborAndRelatedExpense`	$1.65M	USD	1 Quarter
Salaries and payroll-related costs	`LaborAndRelatedExpense`	$2.45M	USD	1 Quarter
Salaries and payroll-related costs	`LaborAndRelatedExpense`	$5.01M	USD	3 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$899.63K	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$1.58M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$2.60M	USD	3 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$3.87M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.76M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$5.46M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$14.72M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$6.39M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$3.76M	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$1.11M	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$363.59K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$2.04M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$276.05K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.08M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.35M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$454.09K	USD	1 Quarter
Impairment expense	`ImpairmentOfIntangibleAssets`	$1.31M	USD	3 Qtrs
Impairment expense	`ImpairmentOfIntangibleAssets`	$1.31M	USD	1 Quarter
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$12.74M	USD	1 Quarter
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$6.43M	USD	1 Quarter
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$16.84M	USD	3 Qtrs
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$31.05M	USD	3 Qtrs
OPERATING LOSS	`OperatingIncomeLoss`	$-30.92M	USD	3 Qtrs
OPERATING LOSS	`OperatingIncomeLoss`	$-6.39M	USD	1 Quarter
OPERATING LOSS	`OperatingIncomeLoss`	$-16.59M	USD	3 Qtrs
OPERATING LOSS	`OperatingIncomeLoss`	$-12.70M	USD	1 Quarter
Equity in income (loss) of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$-69.35K	USD	3 Qtrs
Equity in income (loss) of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$-380.70K	USD	3 Qtrs
Equity in income (loss) of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$-159.53K	USD	1 Quarter
Equity in income (loss) of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$78.70K	USD	1 Quarter
Gain (loss) on sale of fixed assets, net	`GainLossOnSaleOfPropertyPlantEquipment`	$-76.39K	USD	3 Qtrs
Gain (loss) on sale of fixed assets, net	`GainLossOnSaleOfPropertyPlantEquipment`	$-58.88K	USD	3 Qtrs
Gain (loss) on sale of fixed assets, net	`GainLossOnSaleOfPropertyPlantEquipment`	$-39.95K	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNet`	$-48.25K	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNet`	$386.39K	USD	3 Qtrs
Interest income (expense), net	`InterestIncomeExpenseNet`	$-68.40K	USD	3 Qtrs
Interest income (expense), net	`InterestIncomeExpenseNet`	$226.42K	USD	1 Quarter
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$-5.71M	USD	3 Qtrs
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$215.62K	USD	3 Qtrs
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$200.75K	USD	1 Quarter
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$758.47K	USD	1 Quarter
Other income (expense)	`OtherNonoperatingIncomeExpense`	$81.27K	USD	3 Qtrs
Other income (expense)	`OtherNonoperatingIncomeExpense`	$10.05K	USD	1 Quarter
Other income (expense)	`OtherNonoperatingIncomeExpense`	$-997.98K	USD	3 Qtrs
Other income (expense)	`OtherNonoperatingIncomeExpense`	$259.22K	USD	1 Quarter
TOTAL OTHER INCOME (EXPENSE)	`NonoperatingIncomeExpense`	$212.24K	USD	1 Quarter
TOTAL OTHER INCOME (EXPENSE)	`NonoperatingIncomeExpense`	$1.07M	USD	1 Quarter
TOTAL OTHER INCOME (EXPENSE)	`NonoperatingIncomeExpense`	$-5.37M	USD	3 Qtrs
TOTAL OTHER INCOME (EXPENSE)	`NonoperatingIncomeExpense`	$-1.31M	USD	3 Qtrs
LOSS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-6.18M	USD	1 Quarter
LOSS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-17.90M	USD	3 Qtrs
LOSS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-11.63M	USD	1 Quarter
LOSS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-36.29M	USD	3 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	3 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	3 Qtrs
LOSS FROM CONTINUING OPERATIONS	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-11.63M	USD	1 Quarter
LOSS FROM CONTINUING OPERATIONS	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-6.18M	USD	1 Quarter
LOSS FROM CONTINUING OPERATIONS	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-17.90M	USD	3 Qtrs
LOSS FROM CONTINUING OPERATIONS	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-36.29M	USD	3 Qtrs
NET INCOME (LOSS) FROM DISCONTINUED OPERATIONS	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-354.00	USD	3 Qtrs
NET LOSS	`ProfitLoss`	$-36.29M	USD	3 Qtrs
NET LOSS	`ProfitLoss`	$-6.18M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-11.63M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-17.90M	USD	3 Qtrs
Net (gain) loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-95.13K	USD	3 Qtrs
Net (gain) loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-98.62K	USD	1 Quarter
Net (gain) loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-447.27K	USD	3 Qtrs
Net (gain) loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$2.47K	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-11.63M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-6.08M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-36.20M	USD	3 Qtrs
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-17.45M	USD	3 Qtrs
NET LOSS PER SHARE ATTRIBUTABLE TO ARROWHEAD	`EarningsPerShareBasicAndDiluted`	$-0.22	USD	1 Quarter
NET LOSS PER SHARE ATTRIBUTABLE TO ARROWHEAD	`EarningsPerShareBasicAndDiluted`	$-0.81	USD	3 Qtrs
NET LOSS PER SHARE ATTRIBUTABLE TO ARROWHEAD	`EarningsPerShareBasicAndDiluted`	$-0.92	USD	3 Qtrs
NET LOSS PER SHARE ATTRIBUTABLE TO ARROWHEAD	`EarningsPerShareBasicAndDiluted`	$-0.23	USD	1 Quarter
Weighted average shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	51.93M	shares	1 Quarter
Weighted average shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	44.57M	shares	3 Qtrs
Weighted average shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	26.13M	shares	1 Quarter
Weighted average shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	18.89M	shares	3 Qtrs

Cash Flow Statement 90 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-36.29M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-6.18M	USD	1 Quarter
Net loss	`ProfitLoss`	$-11.63M	USD	1 Quarter
Net loss	`ProfitLoss`	$-17.90M	USD	3 Qtrs
Net (gain) loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-95.13K	USD	3 Qtrs
Net (gain) loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-98.62K	USD	1 Quarter
Net (gain) loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-447.27K	USD	3 Qtrs
Net (gain) loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$2.47K	USD	1 Quarter
Net income (loss) attributable to Arrowhead	`NetIncomeLoss`	$-11.63M	USD	1 Quarter
Net income (loss) attributable to Arrowhead	`NetIncomeLoss`	$-6.08M	USD	1 Quarter
Net income (loss) attributable to Arrowhead	`NetIncomeLoss`	$-36.20M	USD	3 Qtrs
Net income (loss) attributable to Arrowhead	`NetIncomeLoss`	$-17.45M	USD	3 Qtrs
Common stock, shares issued	`CommonStockSharesIssued`	52.91M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	32.49M	shares	Point-in-time
(Income) loss from discontinued operations	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax`	$-354.00	USD	3 Qtrs
(Gain) loss on disposal of fixed assets	`GainLossOnSaleOfPropertyPlantEquipment`	$-76.39K	USD	3 Qtrs
Common stock value	`CommonStockValue`	$145.28K	USD	Point-in-time
(Gain) loss on disposal of fixed assets	`GainLossOnSaleOfPropertyPlantEquipment`	$-58.88K	USD	3 Qtrs
(Gain) loss on disposal of fixed assets	`GainLossOnSaleOfPropertyPlantEquipment`	$-39.95K	USD	1 Quarter
Common stock value	`CommonStockValue`	$124.86K	USD	Point-in-time
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$-5.71M	USD	3 Qtrs
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$215.62K	USD	3 Qtrs
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$200.75K	USD	1 Quarter
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$758.47K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$3.76M	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$1.11M	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$363.59K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$2.04M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$276.05K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.08M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.35M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$454.09K	USD	1 Quarter
Amortization (accretion) of note discounts, net	`AmortizationOfDebtDiscountPremium`	$416.29K	USD	3 Qtrs
Amortization (accretion) of note discounts, net	`AmortizationOfDebtDiscountPremium`	$82.34K	USD	3 Qtrs
Non-cash gain in equity investment	`GainLossOnSaleOfEquityInvestments`	$87.20K	USD	3 Qtrs
Non-cash impairment expense	`AssetImpairmentCharges`	$2.32M	USD	3 Qtrs
Non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-95.13K	USD	3 Qtrs
Non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-98.62K	USD	1 Quarter
Non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-447.27K	USD	3 Qtrs
Non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$2.47K	USD	1 Quarter
Receivables	`IncreaseDecreaseInReceivables`	$-9.38K	USD	3 Qtrs
Receivables	`IncreaseDecreaseInReceivables`	$-75.00K	USD	3 Qtrs
Other receivables	`IncreaseDecreaseInOtherReceivables`	$-1.08K	USD	3 Qtrs
Other receivables	`IncreaseDecreaseInOtherReceivables`	$517.99K	USD	3 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$127.25K	USD	3 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$441.37K	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$1.81K	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$11.40K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$183.96K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$990.93K	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$95.13K	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$459.69K	USD	3 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-4.48K	USD	3 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-313.35K	USD	3 Qtrs
NET CASH USED IN OPERATING ACTIVITIES OF CONTINUING OPERATIONS	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-13.64M	USD	3 Qtrs
NET CASH USED IN OPERATING ACTIVITIES OF CONTINUING OPERATIONS	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-24.50M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.25M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$191.66K	USD	3 Qtrs
Proceeds from sale of fixed assets	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$89.50K	USD	3 Qtrs
Purchase of marketable securities	`PaymentsToAcquireMarketableSecurities`	$4.06M	USD	3 Qtrs
Purchase of marketable securities	`PaymentsToAcquireMarketableSecurities`	$46.37M	USD	3 Qtrs
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$1.16M	USD	3 Qtrs
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$6.59M	USD	3 Qtrs
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES OF CONTINUING OPERATIONS	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-3.00M	USD	3 Qtrs
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES OF CONTINUING OPERATIONS	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-41.03M	USD	3 Qtrs
Principal payments on capital leases	`RepaymentsOfLongTermCapitalLeaseObligations`	$160.50K	USD	3 Qtrs
Principal payments on capital leases	`RepaymentsOfLongTermCapitalLeaseObligations`	$257.18K	USD	3 Qtrs
Proceeds from issuance of common stock and preferred stock, net	`ProceedsFromIssuanceOrSaleOfEquity`	$172.64M	USD	3 Qtrs
Proceeds from issuance of common stock and preferred stock, net	`ProceedsFromIssuanceOrSaleOfEquity`	$42.45M	USD	3 Qtrs
Proceeds from the exercise of warrants and stock options	`ProceedsFromExerciseOfWarrantsAndStockOptions`	$12.37M	USD	3 Qtrs
NET CASH PROVIDED BY FINANCING ACTIVITIES OF CONTINUING OPERATIONS	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$184.76M	USD	3 Qtrs
NET CASH PROVIDED BY FINANCING ACTIVITIES OF CONTINUING OPERATIONS	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$42.29M	USD	3 Qtrs
Operating cash flows	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	$-354.00	USD	3 Qtrs
Investing cash flows	`CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations`	-	USD	3 Qtrs
Investing cash flows	`CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations`	-	USD	3 Qtrs
Financing cash flows	`CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations`	-	USD	3 Qtrs
Financing cash flows	`CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations`	-	USD	3 Qtrs
Net cash provided by (used in) discontinued operations:	`NetCashProvidedByUsedInDiscontinuedOperations`	$-354.00	USD	3 Qtrs
NET INCREASE IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$25.65M	USD	3 Qtrs
NET INCREASE IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$119.24M	USD	3 Qtrs
CASH AT BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$138.35M	USD	Point-in-time
CASH AT BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$3.38M	USD	Point-in-time
CASH AT BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$19.11M	USD	Point-in-time
CASH AT BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$29.03M	USD	Point-in-time
CASH AT END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$138.35M	USD	Point-in-time
CASH AT END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$3.38M	USD	Point-in-time
CASH AT END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$19.11M	USD	Point-in-time
CASH AT END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$29.03M	USD	Point-in-time
Interest paid	`InterestPaid`	$32.14K	USD	3 Qtrs
Interest paid	`InterestPaid`	$21.48K	USD	3 Qtrs

Stockholders Equity 17 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$185.81M	USD	Point-in-time
Beginning Balance Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$25.73M	USD	Point-in-time
Exercise of warrants, Amount	`WarrantsExercisedDuringPeriodValue`	$10.00M	USD	3 Qtrs
Stock options exercised	`StockIssuedDuringPeriodSharesStockOptionsExercised`	377,112.00	shares	3 Qtrs
Stock options exercised	`StockIssuedDuringPeriodSharesStockOptionsExercised`	675.00	shares	Annual
Stock options exercised, Amount	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.37M	USD	3 Qtrs
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$3.76M	USD	3 Qtrs
Stock issuances, Shares	`StockIssuedDuringPeriodSharesNewIssues`	3.07M	shares	Point-in-time
Stock issuances, Shares	`StockIssuedDuringPeriodSharesNewIssues`	6.33M	shares	Point-in-time
Settlements related to derivative liability	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax`	$5.79M	USD	3 Qtrs
Deconsolidation of Calando Pharmaceuticals, Inc.	`NoncontrollingInterestDecreaseFromDeconsolidation`	$1.30M	USD	3 Qtrs
Net loss for the nine months ended June 30, 2014	`ProfitLoss`	$-36.29M	USD	3 Qtrs
Net loss for the nine months ended June 30, 2014	`ProfitLoss`	$-6.18M	USD	1 Quarter
Net loss for the nine months ended June 30, 2014	`ProfitLoss`	$-11.63M	USD	1 Quarter
Net loss for the nine months ended June 30, 2014	`ProfitLoss`	$-17.90M	USD	3 Qtrs
Ending Balance Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$185.81M	USD	Point-in-time
Ending Balance Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$25.73M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.